☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search category
Search here
Search here
Subscribe Now
All Posts by Date
Top 20 Life Sciences Deals of 2022 by Total Deal Value
February 8, 2023
UCB’s Fintepla (fenfluramine) Receive EU Approval for Adjunctive Treatment of Seizures Associated with Lennox-Gastaut Syndrome
February 8, 2023
Aldeyra Therapeutics Reports the US FDA Acceptance of NDA for Reproxalap to Treat Dry Eye Disease
February 8, 2023
Wellmarker Bio Entered into a Clinical Trial Collaboration with MSD to evaluate WM-A1-3389 + Keytruda (pembrolizumab) for Non-Smal...
February 8, 2023
Rocket Pharmaceuticals Receives the US FDA’s RMAT Designation of RP-A501 for the Treatment of Danon Disease
February 8, 2023
CNS Pharmaceuticals Reports First Patient Enrollment in Pivotal Global Trial of Berubicin for Recurrent Glioblastoma Multiforme in...
February 8, 2023
Load more...
Back to Home
Stay Connected
LinkedIn
Twitter
Facebook
instagram
Youtube
Join the PharmaShots family of 12000+ subscribers
Newsletter
Subscribe Now
I accept the
Terms and Conditions